Pulmonary arterial hypertension (PAH) is a rare but progressive disorder where high blood pressure is noticed in the pulmonary arteries (arteries of the lungs) for no apparent reason. There is no cure, but advanced pulmonary arterial hypertension treatment includes medications and therapies such as stem cell treatment. Stem cell banking plays a crucial role in ensuring the availability of these innovative therapies, offering hope for an improved quality of life for individuals with PAH.
What is Pulmonary Arterial Hypertension?
Pulmonary Arterial Hypertension (PAH) is an uncommon disease where the arteries in the lungs become narrowed, and the right side of the heart has to work harder to push the blood through the narrowed arteries. The stress can cause the heart to lose the ability to pump enough blood to the lungs to meet the blood requirements of the rest of the body.
There are different types of PAH, like idiopathic PAH, which happens without any clear reason, and inherited PAH, when someone acquires HPAH genes from family members. Patients with other medical conditions affecting the heart, liver, and connective tissue, like HIV, scleroderma, and lupus, may develop PAH. Also, persistent use of drugs, like methamphetamine or certain diet pills, may lead to PAH.
Stem Cell Treatment for Pulmonary Arterial Hypertension
Stem cell treatment is the advanced treatment to cure PAH. The stem cells, with their unique regenerative potential, are then carefully processed and reintroduced into the bloodstream. After entering the body, they search for sites of damage, including blocked pulmonary arteries.
Stem cell therapy aims to initiate pulmonary vascular re-modeling and excessive cell proliferation, slowing the rate of pulmonary hypertension and right heart failure and improving cardiopulmonary function. In simpler terms, it aims to promote healing, reduce swelling, and improve the function of blood vessels. Current research and advances continue to improve the range of applications as well as refine this life-changing treatment.
Benefits of Stem Cell Treatment for Pulmonary Arterial Hypertension
When it comes to treating pulmonary arterial hypertension (PAH), stem cell therapy acts as a beacon of hope. Here are the most significant benefits of stem cells for the treatment of Pulmonary Arterial Hypertension:
- Regenerative Healing: The pulmonary artery’s new, healthy tissues may grow again due to cord blood stem cells.
- Anti-Inflammatory Action: Stem cell research shows that cord blood stem cells have strong anti-inflammatory properties. It is especially helpful in PAH, where inflammation causes arterial damage.
- Improved Blood Flow: Stem cell treatment for PAH involves improving blood vessel function. The object of this therapy is to improve the blood (oxygen) flow inside the lungs, lessening pressure on the heart.
- Disease Modification Potential: Some conventional treatments focus mainly on the symptoms of PAH, but stem cell therapy tackles its root causes. With great promise, this method could adjust the path of unclearly defined disease and provide long-term relief with an improved quality of life for those suffering from PAH.
Wrapping up,
Stem cell treatment for pulmonary arterial hypertension offers a chance at regeneration and restoring the quality of life. However, the source of stem cells can be different: bone marrow and umbilical cord blood.
Stem cells collected from cord blood have more benefits over bone marrow as they are easy to access, there is no harm to the mother or baby during collection, and they have a lesser risk of rejection and graft vs. host disease. When it comes to stem cell banking, no one can beat the legacy Cryoviva holds. Make the initial move in the direction of a better tomorrow by choosing Cryoviva- your ultimate health partner.
